| Pervasive satellite cell contribution to uninjured adult muscle fibers B Pawlikowski, C Pulliam, ND Betta, G Kardon, BB Olwin Skeletal muscle 5, 1-13, 2015 | 176 | 2015 |
| Duchenne and Becker muscular dystrophies: a review of animal models, clinical end points, and biomarker quantification K Wilson, C Faelan, JC Patterson-Kane, DG Rudmann, SA Moore, ... Toxicologic pathology 45 (7), 961-976, 2017 | 70 | 2017 |
| A role for RNA post-transcriptional regulation in satellite cell activation NH Farina, M Hausburg, ND Betta, C Pulliam, D Srivastava, ... Skeletal muscle 2, 1-21, 2012 | 55 | 2012 |
| Validation of a muscle-specific tissue image analysis tool for quantitative assessment of dystrophin staining in frozen muscle biopsies F Aeffner, C Faelan, SA Moore, A Moody, JC Black, JS Charleston, ... Archives of pathology & laboratory medicine 143 (2), 197-205, 2019 | 14 | 2019 |
| Methods for quantitative assessment of mononuclear cells in muscle tissue sections CD Faelan, AJ Milici, JC Black, NT Martin US Patent App. 15/220,393, 2018 | 3 | 2018 |
| DMD CLINICAL THERAPIES II: P. 132Identification of developmental myosin positive fibres acts both as a clinical biomarker for muscle disease and an important component of the … J Tinsley, F Muntoni, G Layton, C Faelan, J Patterson-Kane, ... Neuromuscular Disorders 28, S69, 2018 | 1 | 2018 |
| Significantly reduced muscle damage and inflammation observed in Duchenne muscular dystrophy patients following ezutromid treatment F Muntoni, G Layton, I Bhattacharya, K Vandenborne, C Faelan, ... NEUROMUSCULAR DISORDERS 28, S91-S91, 2018 | | 2018 |
| Identification of developmental myosin positive fibres acts both as a clinical biomarker for muscle disease and an important component of the process to confirm ezutromid … J Tinsley, F Muntoni, G Layton, C Faelan, J Patterson-Kane, ... NEUROMUSCULAR DISORDERS 28, S69-S69, 2018 | | 2018 |
| NEW THERAPEUTIC APPROACHES AND THEIR READOUT: O. 18Significantly reduced muscle damage and inflammation observed in Duchenne muscular dystrophy patients following ezutromid … F Muntoni, G Layton, I Bhattacharya, K Vandenborne, C Faelan, ... Neuromuscular Disorders 28, S91, 2018 | | 2018 |
| Computational alignment of duplex immunohistochemically-stained muscle sections in support of therapies for Duchenne muscular dystrophy L Cerkovnik, J Patterson-Kane, K Ryall, A Milici, J Tinsley, S Moore, ... Neuromuscular Disorders 27, S214, 2017 | | 2017 |
| Collection of high quality muscle biopsies for use in DMD clinical trial analysis; process development and implementation J Tinsley, D Frank, J Dworzak, C Faelan, J Patterson-Kane, H Wolff, ... Neuromuscular Disorders 27, S236-S237, 2017 | | 2017 |
| Analytical validation (based on CLIA & CLSI standards) of utrophin-laminin α2 and MHCd-laminin α2 duplex immunohistochemical assays using Computational Tissue Analysis (cTA … C Faelan, J Tinsley, A Milici, S Moore, J Patterson-Kane Neuromuscular Disorders 27, S214, 2017 | | 2017 |
| Examining Post-Transcriptional Regulation of Skeletal Muscle Satellite Cell Homeostasis, Activation and Fate Determination CD Pulliam University of Colorado at Boulder, 2014 | | 2014 |
| Skeletal muscle BH Annex | | |
Nicholas H. FarinaVerified email at colorado.edu
